JP2001522367A5 - - Google Patents

Download PDF

Info

Publication number
JP2001522367A5
JP2001522367A5 JP1998546624A JP54662498A JP2001522367A5 JP 2001522367 A5 JP2001522367 A5 JP 2001522367A5 JP 1998546624 A JP1998546624 A JP 1998546624A JP 54662498 A JP54662498 A JP 54662498A JP 2001522367 A5 JP2001522367 A5 JP 2001522367A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP1998546624A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001522367A (ja
Filing date
Publication date
Priority claimed from FR9705422A external-priority patent/FR2762841B1/fr
Application filed filed Critical
Publication of JP2001522367A publication Critical patent/JP2001522367A/ja
Publication of JP2001522367A5 publication Critical patent/JP2001522367A5/ja
Abandoned legal-status Critical Current

Links

JP54662498A 1997-04-30 1998-04-30 ホスホジエステラーゼ4−阻害ジアゼピノインドロン Abandoned JP2001522367A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR97/05422 1997-04-30
FR9705422A FR2762841B1 (fr) 1997-04-30 1997-04-30 Diazepino-indolones inhibitrices de phosphodiesterases iv
PCT/EP1998/002827 WO1998049169A1 (en) 1997-04-30 1998-04-30 Phosphodiesterase 4-inhibiting diazepinoindolones

Publications (2)

Publication Number Publication Date
JP2001522367A JP2001522367A (ja) 2001-11-13
JP2001522367A5 true JP2001522367A5 (https=) 2005-12-02

Family

ID=9506517

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54662498A Abandoned JP2001522367A (ja) 1997-04-30 1998-04-30 ホスホジエステラーゼ4−阻害ジアゼピノインドロン

Country Status (17)

Country Link
US (1) US6239130B1 (https=)
EP (1) EP0980374B1 (https=)
JP (1) JP2001522367A (https=)
KR (1) KR20010020386A (https=)
AT (1) ATE232534T1 (https=)
AU (1) AU729495B2 (https=)
BR (1) BR9809429A (https=)
CA (1) CA2278217A1 (https=)
DE (1) DE69811360T2 (https=)
DK (1) DK0980374T3 (https=)
ES (1) ES2190083T3 (https=)
FR (1) FR2762841B1 (https=)
HR (1) HRP980231B1 (https=)
MX (1) MXPA99006979A (https=)
NZ (1) NZ337589A (https=)
WO (1) WO1998049169A1 (https=)
ZA (1) ZA983704B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795731B1 (fr) 1999-07-02 2001-09-07 Warner Lambert Co PROCEDE DE PREPARATION DE [1,4] DIAZEPINO [6,7,1-hi] INDOL-4-ONES SUBSTITUEES
AU2001232175B2 (en) * 2000-03-03 2005-07-07 Pfizer Products Inc. Pyrazole ether derivatives as anti-inflammatory/analgesic agents
EP1161949A1 (en) 2000-06-09 2001-12-12 Warner-Lambert Company Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
ES2427930T3 (es) 2001-05-23 2013-11-04 Mitsubishi Tanabe Pharma Corporation Composición terapéutica para el tratamiento regenerativo de enfermedades de los cartílagos
KR20040007596A (ko) 2001-05-23 2004-01-24 다나베 세이야꾸 가부시키가이샤 골절 치료 촉진용 조성물
WO2003007955A2 (en) * 2001-07-20 2003-01-30 Cancer Research Technology Limited Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
WO2006073413A1 (en) * 2004-02-20 2006-07-13 The Board Of Trustees Of The University Of Illinois Blood pressure reduction in salt-sensitive
US20050239867A1 (en) * 2004-04-23 2005-10-27 Zeldis Jerome B Methods of using and compositions comprising PDE4 modulators for the treatment and management of pulmonary hypertension
NZ561746A (en) * 2005-04-19 2011-09-30 Nycomed Gmbh Roflumilast for the treatment of pulmonary hypertension
WO2008041118A2 (en) * 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
TW200902025A (en) * 2007-04-11 2009-01-16 Alcon Res Ltd Use of an inhibitor of TNF α plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis
CN101784269A (zh) * 2007-06-26 2010-07-21 莱西肯医药有限公司 治疗由5-羟色胺介导的疾病和病症的方法
US20110082145A1 (en) * 2009-10-01 2011-04-07 Alcon Research, Ltd. Olopatadine compositions and uses thereof
NZ777336A (en) 2018-12-28 2026-02-27 Regeneron Pharma Treatment of respiratory disorders with arachidonate 15-lipoxygenase (alox15) inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725719B1 (fr) * 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv

Similar Documents

Publication Publication Date Title
JP2000509942A5 (https=)
JP2000509912A5 (https=)
JP2000510751A5 (https=)
JP2000509637A5 (https=)
JP2000509635A5 (https=)
JP2001527589A5 (https=)
JP2000509587A5 (https=)
JP2000507369A5 (https=)
JP2002508747A5 (https=)
JP2000508866A5 (https=)
JP2000510793A5 (https=)
JP2000508022A5 (https=)
JP2000508841A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2001518893A5 (https=)
JP2000510969A5 (https=)
JP2000510247A5 (https=)
JP2000508102A5 (https=)
JP2000508836A5 (https=)
JP2000509520A5 (https=)
JP2000509818A5 (https=)
JP2001522367A5 (https=)